Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * Disallow: /wp-admin/ Allow: /wp-admin/admin-ajax.php Sitemap: |
Title | Drive |
Description | Drive INFECTIOUS INNOVATION About Focus Areas Collaborations Contact We led the development of molnupiravir , the world’s first oral direct acting antivir |
Keywords | N/A |
WebSite | driveinnovations.org |
Host IP | 72.47.228.180 |
Location | United States |
Site | Rank |
US$2,417,894
Last updated: 2023-05-10 07:18:03
driveinnovations.org has Semrush global rank of 4,377,490. driveinnovations.org has an estimated worth of US$ 2,417,894, based on its estimated Ads revenue. driveinnovations.org receives approximately 278,988 unique visitors each day. Its web server is located in United States, with IP address 72.47.228.180. According to SiteAdvisor, driveinnovations.org is safe to visit. |
Purchase/Sale Value | US$2,417,894 |
Daily Ads Revenue | US$2,232 |
Monthly Ads Revenue | US$66,958 |
Yearly Ads Revenue | US$803,485 |
Daily Unique Visitors | 18,600 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
driveinnovations.org. | A | 600 | IP: 72.47.228.180 |
driveinnovations.org. | NS | 3600 | NS Record: ns76.domaincontrol.com. |
driveinnovations.org. | NS | 3600 | NS Record: ns75.domaincontrol.com. |
driveinnovations.org. | MX | 3600 | MX Record: 10 aspmx.l.google.com. |
driveinnovations.org. | MX | 3600 | MX Record: 30 aspmx2.googlemail.com. |
driveinnovations.org. | MX | 3600 | MX Record: 30 aspmx3.googlemail.com. |
driveinnovations.org. | MX | 3600 | MX Record: 20 alt1.aspmx.l.google.com. |
driveinnovations.org. | MX | 3600 | MX Record: 20 alt2.aspmx.l.google.com. |
driveinnovations.org. | TXT | 3600 | TXT Record: v=spf1 include:_spf.google.com ~all |
driveinnovations.org. | TXT | 3600 | TXT Record: google-site-verification=84ub-LnhF-Wpb43aJ9zTj62Zf7qa2wee2J85DoVEpGs |
Drive INFECTIOUS INNOVATION About Focus Areas Collaborations Contact We led the development of molnupiravir , the world’s first oral direct acting antiviral drug for COVID-19 (A), through IND filing. Interim Phase 3 data showed molnupiravir reduced hospitalization by 50% in mild to moderate COVID-19 patients with at least one risk factor and reduced deaths to zero in that same patient group. See NEWS for latest updates and approvals. We led the development of molnupiravir , the world’s first oral direct acting antiviral drug for COVID-19 (A), through IND filing. Interim Phase 3 data showed molnupiravir reduced hospitalization by 50% in mild to moderate COVID-19 patients with at least one risk factor and reduced deaths to zero in that same patient group. See NEWS for latest updates and approvals. We led the development of molnupiravir , the world’s first oral direct acting antiviral drug for COVID-19 (A), through IND filing. Interim Phase 3 data showed molnupiravir reduced |
Domain Name: DRIVEINNOVATIONS.ORG Registry Domain ID: D168014074-LROR Registrar WHOIS Server: whois.godaddy Registrar URL: http://www.whois.godaddy.com Updated Date: 2020-02-24T15:48:36Z Creation Date: 2013-02-27T22:52:31Z Registry Expiry Date: 2023-02-27T22:52:31Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: +1.4806242505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Registrant State/Province: GA Registrant Country: US Name Server: NS75.DOMAINCONTROL.COM Name Server: NS76.DOMAINCONTROL.COM DNSSEC: unsigned URL of the ICANN Whois Inaccuracy Complaint Form https://www.icann.org/wicf/) >>> Last update of WHOIS database: 2021-09-20T17:05:24Z <<< |